Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Clinical trial NCT04361552 · WITHDRAWN

Trial details

NCT number: NCT04361552
Sponsor: Emory University
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Cerebrovascular Accident Chronic Obstructive Pulmonary Disease Chronic Renal Failure Coronary Artery Disease Diabetes Mellitus Malignant Neoplasm SARS Coronavirus 2 Infection

Start date: 2020-04-07
Primary completion: 2020-06-02
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.